false2021Q100011591671/100011591672021-01-032021-04-03xbrli:shares00011591672021-04-30iso4217:USD00011591672021-04-0300011591672021-01-02iso4217:USDxbrli:shares00011591672019-12-292020-03-280001159167us-gaap:CommonStockMember2021-01-020001159167us-gaap:AdditionalPaidInCapitalMember2021-01-020001159167us-gaap:RetainedEarningsMember2021-01-020001159167us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-020001159167us-gaap:CommonStockMember2021-01-032021-04-030001159167us-gaap:AdditionalPaidInCapitalMember2021-01-032021-04-030001159167us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-032021-04-030001159167us-gaap:RetainedEarningsMember2021-01-032021-04-030001159167us-gaap:CommonStockMember2021-04-030001159167us-gaap:AdditionalPaidInCapitalMember2021-04-030001159167us-gaap:RetainedEarningsMember2021-04-030001159167us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-04-030001159167us-gaap:CommonStockMember2019-12-280001159167us-gaap:AdditionalPaidInCapitalMember2019-12-280001159167us-gaap:RetainedEarningsMember2019-12-280001159167us-gaap:AccumulatedOtherComprehensiveIncomeMember2019-12-2800011591672019-12-280001159167us-gaap:CommonStockMember2019-12-292020-03-280001159167us-gaap:AdditionalPaidInCapitalMember2019-12-292020-03-280001159167us-gaap:RetainedEarningsMember2019-12-292020-03-280001159167us-gaap:CommonStockMember2020-03-280001159167us-gaap:AdditionalPaidInCapitalMember2020-03-280001159167us-gaap:RetainedEarningsMember2020-03-280001159167us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-03-2800011591672020-03-2800011591672020-07-012020-07-010001159167country:US2021-01-032021-04-030001159167country:US2019-12-292020-03-280001159167us-gaap:EMEAMember2021-01-032021-04-030001159167us-gaap:EMEAMember2019-12-292020-03-280001159167country:JP2021-01-032021-04-030001159167country:JP2019-12-292020-03-280001159167irbt:AllOtherRegionsMember2021-01-032021-04-030001159167irbt:AllOtherRegionsMember2019-12-292020-03-28xbrli:pure0001159167us-gaap:DesignatedAsHedgingInstrumentMember2021-01-032021-04-030001159167us-gaap:DesignatedAsHedgingInstrumentMember2021-04-030001159167us-gaap:DesignatedAsHedgingInstrumentMember2021-01-020001159167us-gaap:NondesignatedMember2021-04-030001159167us-gaap:NondesignatedMember2021-01-020001159167us-gaap:NondesignatedMemberus-gaap:EquitySecuritiesMember2021-04-030001159167us-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMemberus-gaap:OtherCurrentAssetsMember2021-04-030001159167us-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMemberus-gaap:OtherCurrentAssetsMember2021-01-020001159167us-gaap:AccruedLiabilitiesMemberus-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMember2021-04-030001159167us-gaap:AccruedLiabilitiesMemberus-gaap:NondesignatedMemberus-gaap:ForeignExchangeForwardMember2021-01-020001159167us-gaap:AccruedLiabilitiesMemberus-gaap:NondesignatedMemberus-gaap:DerivativeForwardPrice2021-04-030001159167us-gaap:AccruedLiabilitiesMemberus-gaap:NondesignatedMemberus-gaap:DerivativeForwardPrice2021-01-020001159167us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeForwardMemberus-gaap:OtherCurrentAssetsMember2021-04-030001159167us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeForwardMemberus-gaap:OtherCurrentAssetsMember2021-01-020001159167us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeForwardMemberus-gaap:OtherNoncurrentAssetsMember2021-04-030001159167us-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeForwardMemberus-gaap:OtherNoncurrentAssetsMember2021-01-020001159167us-gaap:AccruedLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeForwardMember2021-04-030001159167us-gaap:AccruedLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeForwardMember2021-01-020001159167us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeForwardMember2021-04-030001159167us-gaap:OtherNoncurrentLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeForwardMember2021-01-020001159167us-gaap:OtherNonoperatingIncomeExpenseMember2021-01-032021-04-030001159167us-gaap:OtherNonoperatingIncomeExpenseMember2019-12-292020-03-280001159167us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeForwardMember2021-01-032021-04-030001159167us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeForwardMember2019-12-292020-03-280001159167us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeForwardMemberus-gaap:SalesMember2021-01-032021-04-030001159167us-gaap:CashFlowHedgingMemberus-gaap:ForeignExchangeForwardMemberus-gaap:SalesMember2019-12-292020-03-280001159167us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-04-030001159167us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2021-04-030001159167us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-04-030001159167us-gaap:FairValueInputsLevel1Memberus-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2021-01-020001159167us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2021-01-020001159167us-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-01-020001159167us-gaap:EquitySecuritiesMember2021-01-020001159167us-gaap:FairValueInputsLevel1Memberus-gaap:EquitySecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2021-01-020001159167us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2021-01-020001159167us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-01-020001159167us-gaap:BondsMember2021-01-020001159167us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2021-01-0200011591672018-02-270001159167srt:ScenarioForecastMember2021-09-050001159167us-gaap:SubsequentEventMember2021-04-042021-05-060001159167us-gaap:SubsequentEventMember2021-05-0600011591672020-06-2700011591672020-03-292020-06-27irbt:segment0001159167us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2021-01-032021-04-030001159167us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMember2019-12-292020-03-28
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
______________________________________________ 
FORM 10-Q
 ______________________________________________
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE QUARTERLY PERIOD ENDED April 3, 2021
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE TRANSITION PERIOD FROM              TO             
COMMISSION FILE NUMBER 001-36414
______________________________________________ 
iROBOT CORPORATION
(Exact name of registrant as specified in its charter)
 ______________________________________________
Delaware77-0259335
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
8 Crosby Drive
Bedford, MA 01730
(Address of principal executive offices, including zip code)

(781) 430-3000
(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $0.01 par valueIRBTThe Nasdaq Stock Market LLC
______________________________________________ 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  x    No  o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
        

Large accelerated filerAccelerated filer
Non-accelerated filerSmaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o    
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes      No  x 
The number of shares outstanding of the Registrant’s Common Stock as of April 30, 2021 was 28,094,994.
        



iROBOT CORPORATION
FORM 10-Q
FOR THE QUARTER ENDED APRIL 3, 2021
INDEX
 Page
PART I: FINANCIAL INFORMATION
Item 1. Financial Statements (unaudited)
2





iROBOT CORPORATION
CONSOLIDATED BALANCE SHEETS
(in thousands, except per share amounts)
(unaudited)
 
April 3, 2021January 2, 2021
ASSETS
Current assets:
Cash and cash equivalents$500,754 $432,635 
Short term investments 51,081 
Accounts receivable, net67,918 170,526 
Inventory233,113 181,756 
Other current assets41,369 45,223 
   Total current assets843,154 881,221 
Property and equipment, net80,402 76,584 
Operating lease right-of-use assets42,086 43,682 
Deferred tax assets33,408 33,404 
Goodwill123,273 125,872 
Intangible assets, net9,312 9,902 
Other assets26,256 19,063 
   Total assets$1,157,891 $1,189,728 
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable$150,769 $165,779 
Accrued expenses105,810 131,388 
Deferred revenue and customer advances7,294 10,400 
   Total current liabilities263,873 307,567 
Operating lease liabilities48,738 50,485 
Deferred tax liabilities584 705 
Other long-term liabilities20,712 26,537 
   Total long-term liabilities70,034 77,727 
   Total liabilities333,907 385,294 
Commitments and contingencies (Note 10)
Preferred stock, 5,000 shares authorized and none outstanding
  
Common stock, $0.01 par value, 100,000 shares authorized; 28,395 and 28,184 shares issued and outstanding, respectively
284 282 
Additional paid-in capital209,890 205,256 
Retained earnings606,832 599,389 
Accumulated other comprehensive income (loss)6,978 (493)
   Total stockholders’ equity823,984 804,434 
   Total liabilities and stockholders’ equity$1,157,891 $1,189,728 
The accompanying notes are an integral part of the consolidated financial statements.
3



iROBOT CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share amounts)
(unaudited)
 
 Three Months Ended
 April 3, 2021March 28, 2020
Revenue$303,261 $192,535 
Cost of revenue:
Cost of product revenue180,092 114,295 
Amortization of acquired intangible assets225 285 
Total cost of revenue
180,317 114,580 
Gross profit122,944 77,955 
Operating expenses:
Research and development41,920 36,759 
Selling and marketing50,990 36,594 
General and administrative23,440 24,573 
Amortization of acquired intangible assets205 254 
Total operating expenses116,555 98,180 
Operating income (loss)6,389 (20,225)
Other expense, net(160)(19)
Income (loss) before income taxes6,229 (20,244)
Income tax benefit(1,214)(2,109)
Net income (loss)$7,443 $(18,135)
Net income (loss) per share:
Basic$0.26 $(0.64)
Diluted$0.26 $(0.64)
Number of shares used in per share calculations:
Basic28,257 28,297 
Diluted29,086 28,297 
The accompanying notes are an integral part of the consolidated financial statements.
4



iROBOT CORPORATION
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(in thousands)
(unaudited)
 
 Three Months Ended
 April 3, 2021March 28, 2020
Net income (loss)$7,443 $(18,135)
Other comprehensive income (loss):
Net foreign currency translation adjustments(5,883)(914)
Net unrealized gains on cash flow hedges, net of tax12,967 5,674 
Net losses (gains) on cash flow hedge reclassified into earnings, net of tax391 (1,468)
Net unrealized losses on marketable securities, net of tax(4)(17)
Total comprehensive income (loss)$14,914 $(14,860)
The accompanying notes are an integral part of the consolidated financial statements.
5



iROBOT CORPORATION
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY
(in thousands)
(unaudited)
Common StockAdditional
Paid-In
Capital
Retained
Earnings
Accumulated Other Comprehensive Income (Loss) ("AOCI")Stockholders’
Equity
SharesValue
Balance at January 2, 202128,184 $282 $205,256 $599,389 $(493)$804,434 
Issuance of common stock under employee stock plans67 1 2,588 2,589 
Vesting of restricted stock units185 2 (2) 
Stock-based compensation6,782 6,782 
Stock withheld to cover tax withholdings requirements upon restricted stock vesting(41)(1)(4,755)(4,756)
Other comprehensive income7,471 7,471 
Directors' deferred compensation21 21 
Net income7,443 7,443 
Balance at April 3, 202128,395 $284 $209,890 $606,832 $6,978 $823,984 
Common StockAdditional
Paid-In
Capital
Retained
Earnings
Accumulated
Other
Comprehensive
Income (Loss) ("AOCI")
Stockholders’
Equity
SharesValue
Balance at December 28, 201928,352 $284 $196,455 $452,321 $3,009 $652,069 
Issuance of common stock under employee stock plans40  934 934 
Vesting of restricted stock units193 2 (2) 
Stock-based compensation5,191 5,191 
Stock withheld to cover tax withholdings requirements upon restricted stock vesting(45) (1,816)(1,816)
Other comprehensive income3,275 3,275 
Directors' deferred compensation21 21 
Stock repurchases(664)(7)(24,993)(25,000)
Net loss(18,135)(18,135)
Balance at March 28, 202027,876 $279 $175,790 $434,186 $6,284 $616,539 
The accompanying notes are an integral part of the consolidated financial statements.

6



iROBOT CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(unaudited)
 Three Months Ended
 April 3, 2021March 28, 2020
Cash flows from operating activities:
Net income (loss)$7,443 $(18,135)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization7,501 7,459 
Stock-based compensation6,782 5,191 
Deferred income taxes, net(95)(528)
Other 1,582 1,531 
Changes in operating assets and liabilities — (use) source
Accounts receivable101,459 108,825 
Inventory(51,443)9,848 
Other assets3,425 (5,612)
Accounts payable(15,438)(41,440)
Accrued expenses and other liabilities(32,522)(26,405)
Net cash provided by operating activities28,694 40,734 
Cash flows from investing activities:
Additions of property and equipment(11,272)(7,310)
Purchases of investments(8,664)(1,560)
Sales and maturities of investments63,644 3,500 
Net cash provided by (used in) investing activities43,708 (5,370)
Cash flows from financing activities:
Proceeds from employee stock plans2,589 934 
Income tax withholding payment associated with restricted stock vesting(4,756)(1,816)
Stock repurchases (25,000)
Net cash used in financing activities(2,167)(25,882)
Effect of exchange rate changes on cash and cash equivalents(2,116)(106)
Net increase in cash and cash equivalents68,119 9,376 
Cash and cash equivalents, at beginning of period432,635 239,392 
Cash and cash equivalents, at end of period$500,754 $248,768 
The accompanying notes are an integral part of the consolidated financial statements.
7



iROBOT CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(unaudited)
1. Description of Business
iRobot Corporation ("iRobot" or the "Company") designs and builds robots that empower people to do more. iRobot's consumer robots help people find smarter ways to clean and accomplish more in their daily lives. The Company's portfolio of floor cleaning robots features proprietary technologies for the connected home and advanced concepts in cleaning, mapping and navigation, human-robot interaction and physical solutions. Leveraging this portfolio, the Company's engineers are building an ecosystem of robots to help realize the smart home's potential. The Company’s revenue is primarily generated from product sales through a variety of distribution channels, including chain stores and other national retailers, through the Company's own website and app, dedicated e-commerce websites, the online arms of traditional retailers and through value-added distributors and resellers worldwide.
2. Summary of Significant Accounting Policies
Basis of Presentation and Foreign Currency Translation
The accompanying consolidated financial statements include those of iRobot and its subsidiaries, after elimination of all intercompany balances and transactions. iRobot has prepared the accompanying unaudited consolidated financial statements in conformity with accounting principles generally accepted in the United States of America ("GAAP").
In the opinion of management, all adjustments necessary to the unaudited interim consolidated financial statements have been made to state fairly the Company's financial position. Interim results are not necessarily indicative of results for the full fiscal year or any future periods. The information included in this Form 10-Q should be read in conjunction with the Company's audited consolidated financial statements and notes thereto included in its Annual Report on Form 10-K for the fiscal year ended January 2, 2021, filed with the Securities and Exchange Commission on February 16, 2021.
The Company operates and reports using a 52-53 week fiscal year ending on the Saturday closest to December 31. Accordingly, the Company’s fiscal quarters end on the Saturday that falls closest to the last day of the third month of each quarter.
Recently Adopted Accounting Standards
In December 2019, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2019-12, "Income Taxes - Simplifying the Accounting for Income Taxes." The ASU simplifies the accounting for income taxes by removing certain exceptions to the general principles as well as clarifying and amending existing guidance to improve consistent application. The amendments to this ASU are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020, with early adoption permitted. Depending on the amendment, adoption may be applied on the retrospective, modified retrospective or prospective basis. The Company adopted the standard in the first quarter of 2021 and the adoption had no impact on the Company's consolidated financial statements.
Recently Issued Accounting Standards
From time to time, new accounting pronouncements are issued by FASB that are adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that recently issued standards, which are not yet effective, will not have a material impact on the Company’s consolidated financial statements upon adoption.
Use of Estimates
The preparation of these financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and revenue and expenses. These estimates and judgments include, but are not limited to, revenue recognition, including performance obligations, variable consideration and other obligations such as product returns and incentives; allowance for credit losses; product warranties; valuation of goodwill and acquired intangible assets; valuation of non-marketable equity investments; evaluating loss contingencies; accounting for stock-based compensation including performance-based assessments; and accounting for income taxes and related valuation allowances. The Company bases these estimates and judgments on historical experience, market participant fair value considerations, projected future cash flows and various other factors that the Company believes are reasonable under the circumstances. Actual results may differ from the Company’s estimates.
As of April 3, 2021, the impact of the COVID-19 pandemic remains dynamic and the nature and extent of its full impact on the Company's financial and operational results will depend on several factors, including but not limited to, the duration and severity of the pandemic, advances in treatment and prevention, as well as the macroeconomic impact resulting from global responses to slow the spread of the pandemic. As a result, certain of our estimates and assumptions, including the allowance for credit losses and the valuation of non-marketable equity securities, including our impairment assessment, require increased
8

iROBOT CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)
judgment and carry a higher degree of variability and volatility, which could result in material changes to our estimates in future periods.
Credit Losses
The Company is exposed to credit losses primarily through sales of its products. The Company assesses each customer's ability to pay by conducting a credit review which includes consideration of established credit ratings or an internal assessment of the customer's creditworthiness based on an analysis of their financial information when a credit rating is not available. The Company monitors the credit exposure through active review of customer balances. The Company's expected loss methodology for accounts receivable is developed through consideration of factors including, but not limited to, historical collection experience, current customer credit ratings, current and future economic and market conditions and age of the receivable. Although the Company historically has not experienced significant credit losses as it relates to trade accounts receivable, the COVID-19 pandemic has caused uncertainty in some customer accounts. The Company recorded its estimate of credit losses, resulting in a decrease to the reserve and bad debt expense, of $2.1 million during the three months ended April 3, 2021. As of April 3, 2021 and January 2, 2021, the Company had an allowance for credit losses of $2.7 million and $4.8 million, respectively.
Inventory
Inventory is stated at the lower of cost or net realizable value with cost being determined using the first-in, first-out method. The Company writes down its inventory for estimated obsolescence or excess inventory based upon assumptions around market conditions and estimates of future demand. Adjustments to reduce inventory to net realizable value are recognized in cost of revenue and have not been significant for the periods presented. Inventory primarily consists of finished goods at April 3, 2021 and January 2, 2021.
Strategic Investments
The Company holds non-marketable equity securities as part of its strategic investments portfolio. The Company classifies the majority of these securities as equity securities without readily determinable fair values and measures these investments at cost, less any impairment, adjusted for observable price changes. These investments are valued using significant unobservable inputs or data in an inactive market and the valuation requires the Company's judgment due to the absence of market prices and inherent lack of liquidity. The estimated fair value is based on quantitative and qualitative factors including, but not limited to, subsequent financing activities by the investee and projected discounted cash flows. At April 3, 2021 and January 2, 2021, the Company's equity securities without readily determinable fair values totaled $17.5 million and $17.4 million, respectively, and are included in other assets on the consolidated balance sheets.
On July 1, 2020, Teladoc Health, Inc. ("Teladoc") closed on its previously announced acquisition of InTouch Health, of which the Company held non-marketable equity securities. In exchange for its shares of InTouch Health, the Company received 0.2 million shares of Teladoc and recorded a gain of $38.6 million to other income, net during the second quarter of 2020. The Teladoc shares received were subject to time based contractual sales restrictions which expired in January 2021. These shares were accounted for as marketable equity securities and measured at fair value with unrealized gains and losses recognized in other income, net at the end of each reporting period. As a result, the Company entered into an economic hedge in July 2020 to reduce the Company's exposure to stock price fluctuations during the restricted period. During the three months ended April 3, 2021, the Company received net proceeds of $51.5 million related to the sale of Teladoc shares with gross proceeds of $60.1 million, net of settlement payment of $8.6 million for the related economic hedge.
Net Income Per Share
Basic income per share is calculated using the Company's weighted-average outstanding common shares. Diluted income
per share is calculated using the Company's weighted-average outstanding common shares including the dilutive effect of stock
awards as determined under the treasury stock method.
9

iROBOT CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)
The following table presents the calculation of both basic and diluted net income (loss) per share (in thousands, except per share amounts): 
 Three Months Ended
 April 3, 2021March 28, 2020
Net income (loss)$7,443 $(18,135)
Basic weighted-average common shares outstanding28,257 28,297 
Dilutive effect of employee stock awards829  
Diluted weighted-average common shares outstanding29,086 28,297 
Net income (loss) per share - Basic$0.26 $(0.64)
Net income (loss) per share - Diluted$0.26 $(0.64)
Employee stock awards representing approximately nil and 0.8 million shares of common stock for the three months ended April 3, 2021 and March 28, 2020, respectively, were excluded from the computation of diluted earnings per share as their effect would have been antidilutive.

3. Revenue Recognition
The Company primarily derives its revenue from the sale of consumer robots and accessories. The Company sells products directly to consumers through online stores and indirectly through resellers and distributors. Revenue is recognized upon transfer of control of promised products or services to customers, generally as title and risk of loss pass, in an amount that reflects the consideration the Company expects to receive in exchange for those products or services. Revenue is recognized only to the extent that it is probable that a significant reversal of revenue will not occur and when collection is considered probable. Taxes collected from customers, which are subsequently remitted to governmental authorities, are excluded from revenue. Shipping and handling expenses are considered fulfillment activities and are expensed as incurred.
The Company’s consumer robots are highly dependent on, and interrelated with, the embedded software and cannot function without the software. As such, the consumer robots are accounted for as a single performance obligation, and the revenue is recognized at a point in time when the control is transferred to distributors, resellers or directly to end customers through online stores. For certain consumer robots with Wi-Fi capability ("connected robots"), each sale represents an arrangement with multiple promises consisting of the robot, downloadable free app, cloud services and potential future unspecified software upgrades. The Company has determined that the app, cloud services and potential future unspecified software upgrades represent one promised service to the customer to enhance the functionality and interaction with the robot (referred to collectively as "Cloud Services").
For contracts that contain multiple performance obligations, the transaction price is allocated to each performance obligation based on a relative standalone selling price ("SSP"). The Company estimates SSP for items that are not sold separately, using market data if available or analysis of the cost of providing the products or services plus a reasonable margin. The transaction price allocated to the robots is recognized as revenue at a point in time when control is transferred and when collection is considered probable. The transaction price allocated to the Cloud Services is deferred and recognized on a straight-line basis over the estimated term of the Cloud Services. For contracts with a duration of greater than one year, the transaction price allocated to performance obligations that are unsatisfied as of April 3, 2021 and January 2, 2021 was $13.1 million and $11.5 million, respectively. The Company does not disclose the value of unsatisfied performance obligations for contracts with an original expected duration of one year or less.
The Company’s products generally carry a one-year or two-year limited warranty that promises customers that delivered products are as specified. The Company does not consider these assurance-type warranties as a separate performance obligation and therefore, the Company accounts for such warranties under ASC 460, "Guarantees." During the fourth quarter of 2020, the Company began offering its customers the option to purchase an extended warranty for a fee. Amounts paid for the extended warranty plans are deferred and recognized as revenue on a straight-line basis over the service period.
The Company provides limited rights of returns for direct-to-consumer sales generated through its online stores and certain resellers and distributors. The Company records an allowance for product returns based on specific terms and conditions included in the customer agreements or based on historical experience and the Company's expectation of future returns. In addition, the Company may provide other credits or incentives which are accounted for as variable consideration when estimating the amount of revenue to recognize. Where appropriate, these estimates take into consideration relevant factors such as the Company’s historical experience, current contractual requirements, specific known market events and forecasted inventory level in the channels. Overall, these reserves reflect the Company’s best estimates, and the actual amounts of consideration ultimately received may differ from the Company’s estimates. Returns and credits are estimated at the time of sale and updated at the end of each reporting period as additional information becomes available. As of April 3, 2021, the
10

iROBOT CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)
Company has reserves for product returns of $51.8 million and other credits and incentives of $78.3 million. As of January 2, 2021, the Company had reserves for product returns of $64.3 million and other credits and incentives of $142.2 million. Revenue recognized during the three months ended April 3, 2021 and March 28, 2020 related to performance obligations satisfied in a prior period was not material.
Disaggregation of Revenue
The following table provides information about disaggregated revenue by geographical region (in thousands):
Three Months Ended
April 3, 2021March 28, 2020
United States$114,772 $81,967 
EMEA116,233 66,659 
Japan40,575 26,464 
Other31,681 17,445 
Total revenue$303,261 $192,535 
Contract Balances
The following table provides information about receivables and contract liabilities from contracts with customers (in thousands):
April 3, 2021January 2, 2021
Accounts receivable, net$67,918 $170,526 
Contract liabilities14,986 17,700 
The Company invoices customers based upon contractual billing schedules, and accounts receivable are recorded when the right to consideration becomes unconditional. Contract liabilities include deferred revenue associated with the Cloud Services and extended warranty plans as well as prepayments received from customers in advance of product shipments. The change in the opening and closing balances of the Company’s contract assets and contract liabilities primarily results from the timing difference between the Company’s performance and the customer’s payment. During the three months ended April 3, 2021 and March 28, 2020, the Company recognized $7.3 million and $3.6 million, respectively, of the contract liability balance as revenue upon transfer of the products or services to customers.

4. Leases
The Company's leasing arrangements primarily consist of operating leases for its facilities which include corporate, sales and marketing and research and development offices and equipment under various non-cancelable lease arrangements. For leases with terms greater than 12 months, the Company records the related right-of-use asset and lease obligation at the present value of lease payments over the term. Leases with an initial term of 12 months or less are not recorded on the balance sheet. Lease expense is recognized on a straight-line basis over the lease term. The Company's leases typically include rental escalation clauses, renewal options and/or termination options that are factored into the determination of lease payments when appropriate. The Company does not separate lease and nonlease components of contracts and excludes all variable lease payments from the measurement of right-of-use assets and lease liabilities. The Company's variable lease payments generally include usage based nonlease components. The Company's lease agreements do not contain any residual value guarantees or restrictive covenants.
The Company's existing leases do not provide a readily determinable implicit rate. Therefore, the Company estimates its incremental borrowing rate to discount the lease payments based on information available at December 30, 2018 (date of initial application) or the lease commencement date for new leases post adoption. At April 3, 2021, the Company's weighted average discount rate was 3.57%, while the weighted average remaining lease term was 8.14 years.
The components of lease expense were as follows (in thousands):
Three Months Ended
April 3, 2021March 28, 2020
Operating lease cost$1,987 $2,355 
Variable lease cost895 1,122 
Total lease cost$2,882 $3,477 
11

iROBOT CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)
Supplemental cash flow information related to leases was as follows (in thousands):
Three Months Ended
April 3, 2021March 28, 2020
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases$2,279 $2,021 
Right-of-use assets obtained in exchange for lease obligations:
Operating leases$ $ 
Maturities of operating lease liabilities were as follows as of April 3, 2021 (in thousands):
Remainder of 2021$5,896 
20228,590 
20237,651 
20246,595 
20256,621 
Thereafter28,562 
Total minimum lease payments$63,915 
Less: imputed interest8,955 
Present value of future minimum lease payments$54,960 
Less: current portion of operating lease liabilities (Note 6)6,222 
Long-term lease liabilities$48,738 

5. Goodwill and Other Intangible Assets
The following table summarizes the activity in the carrying amount of goodwill and intangible assets for the three months ended April 3, 2021 (in thousands):
GoodwillIntangible assets
Balance as of January 2, 2021$125,872 $9,902 
Amortization— (430)
Effect of foreign currency translation(2,599)(160)
Balance as of April 3, 2021$123,273 $9,312 


12

iROBOT CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)
6. Accrued Expenses
Accrued expenses consisted of the following at (in thousands):
April 3, 2021January 2, 2021
Accrued warranty$23,904 $24,392 
Accrued manufacturing and logistics cost19,374 20,093 
Accrued compensation and benefits17,452 17,635 
Accrued bonus6,817 31,523 
Current portion of operating lease liabilities6,222 6,315 
Accrued income taxes6,136 3,806 
Accrued sales and other indirect taxes payable5,631 15,480 
Accrued other20,274 12,144 
$105,810 $131,388 

7. Derivative Instruments and Hedging Activities
The Company operates internationally and, in the normal course of business, is exposed to fluctuations in foreign currency exchange rates. The foreign currency exposures typically arise from transactions denominated in currencies other than the functional currency of the Company's operations, primarily the British Pound, Canadian Dollar, Euro and Japanese Yen. The Company uses derivative instruments that are designated in cash flow hedge relationships to reduce or eliminate the effects of foreign exchange rate change on sales. These contracts typically have maturities of three years or less. At April 3, 2021 and January 2, 2021, the Company had outstanding cash flow hedges with a total notional value of $397.8 million and $431.9 million, respectively.
The Company also enters into economic hedges that are not designated as hedges from an accounting standpoint to reduce or eliminate the effects of foreign exchange rate changes typically related to short term trade receivables and payables. These contracts typically have maturities of twelve months or less. At April 3, 2021 and January 2, 2021, the Company had outstanding foreign currency economic hedges with a total notional value of $140.5 million and $192.2 million, respectively.
As described in Note 2, during July 2020, the Company entered into a forward sale contract as an economic hedge to reduce the Company's exposure to stock price fluctuations on one of its marketable equity securities. The contract had a maturity date of January 2021 and was settled during the three months ended April 3, 2021. The total notional value of this economic hedge was $51.5 million at January 2, 2021.
The fair values of derivative instruments are as follows (in thousands):
Fair Value
ClassificationApril 3, 2021January 2, 2021
Derivatives not designated as hedging instruments:
Foreign currency forward contractsOther current assets$1,258 $261 
Foreign currency forward contractsAccrued expenses764 2,176 
Forward sale contractAccrued expenses 3,904 
Derivatives designated as cash flow hedges:
Foreign currency forward contractsOther current assets$6,073 $362 
Foreign currency forward contractsOther assets5,750 679 
Foreign currency forward contractsAccrued expenses1,124 2,092 
Foreign currency forward contractsLong-term liabilities2,633 8,554 

13

iROBOT CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)
Gains (losses) associated with derivative instruments not designated as hedging instruments are as follows (in thousands):
Three Months Ended
ClassificationApril 3, 2021March 28, 2020
Loss recognized in incomeOther expense, net$(10,013)$(545)

The following tables reflect the effect of derivatives designated as cash flow hedging (in thousands): 
Gain (loss) recognized in OCI on Derivative (1)
Three Months Ended
April 3, 2021March 28, 2020
Foreign currency forward contracts$17,154 $7,566 
(1)The amount represents the change in fair value of derivative contracts due to changes in spot rates.
Gain (loss) recognized in earnings on cash flow hedging instruments
Three Months Ended
April 3, 2021March 28, 2020
Revenue
Consolidated statements of operations in which the effects of cash flow hedging instruments are recorded$303,261 $192,535 
(Loss) gain on cash flow hedging relationships:
Foreign currency forward contracts:
Amount of (loss) gain reclassified from AOCI into earnings$(517)$1,957 

8. Fair Value Measurements
The Company’s financial assets and liabilities measured at fair value on a recurring basis were as follows (in thousands):
 Fair Value Measurements as of
April 3, 2021
Level 1Level 2 (1)Level 3
Assets:
Money market funds$338,868 $ $ 
Derivative instruments (Note 7) 13,081  
Total assets measured at fair value$338,868 $13,081 $ 
Liabilities:
Derivative instruments (Note 7)$ $4,521 $ 
Total liabilities measured at fair value$ $4,521 $ 
14

iROBOT CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)
 Fair Value Measurements as of
January 2, 2021
 Level 1Level 2 (1)Level 3
Assets:
Money market funds$47,529 $ $ 
Marketable equity securities, $46,578 at cost
47,576   
Corporate and government bonds, $3,498 at cost
 3,505  
Derivative instruments (Note 7) 5,206  
Total assets measured at fair value$95,105 $8,711 $ 
Liabilities:
Derivative instruments (Note 7)$ $12,822 $ 
Total liabilities measured at fair value$ $12,822 $ 
(1)Level 2 fair value estimates are based on observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

9. Stockholders' Equity
Share Repurchase Activity
The Company's Board of Directors approved a stock repurchase program authorizing up to $200.0 million in share repurchases from time to time until September 5, 2021. On March 11, 2021, the Company entered into a Rule 10b5-1 plan to repurchase $50.0 million of common stock in the aggregate beginning April 12, 2021 and ending September 5, 2021. The Company repurchased 446,954 shares of its common stock at an average price of $111.85, totaling $50.0 million during the second quarter of 2021. As of May 6, 2021, $125.0 million remained available for future repurchases under the program. On March 10, 2020, the Company entered into a Rule 10b5-1 plan to repurchase $25.0 million of common stock in the aggregate beginning March 13, 2020 and ending April 30, 2020. The Company repurchased 663,602 shares of its common stock at an average price of $37.65, totaling $25.0 million in March 2020.

10. Commitments and Contingencies
Legal Proceedings
From time to time and in the ordinary course of business, the Company is subject to various claims, charges and litigation. The outcome of litigation cannot be predicted with certainty and some lawsuits, claims or proceedings may be disposed of unfavorably to us, which could materially affect our financial condition or results of operations. For the following litigation matters, a liability is not probable or the amount cannot be reasonably estimated and therefore accruals have not been made.
On October 24, 2019, purported Company shareholder Miramar Firefighters’ Pension Fund filed a putative class action in the U.S. District Court for the Southern District of New York against the Company and certain of its directors and officers, captioned Miramar Firefighters’ Pension Fund v. iRobot Corporation, et al., No. 1:19-cv-09837.  The case has been transferred to the U.S. District Court for the District of Massachusetts. A similar case captioned Campbell v. iRobot Corporation, et al., No. 1:19-cv-12483 was also filed in the U.S. District Court for the Southern District of New York and subsequently transferred to the U.S. District Court for the District of Massachusetts. On January 24, 2020, the Court consolidated the Miramar and Campbell cases (the consolidated cases together, the "Securities Class Action") and appointed a lead plaintiff and lead plaintiff's Counsel. On April 3, 2020, the plaintiff filed an amended complaint alleging violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder based on allegedly false and misleading statements and omissions concerning the impact of competition and Section 301 tariffs on the Company’s financial performance, and the Company has filed a motion to dismiss the case. On March 15, 2021, the Court granted the Company’s motion to dismiss and therefore dismissed the Securities Class Action.
On December 20, 2019, purported Company shareholders David Katz and Thomas Wightman, derivatively on behalf of iRobot Corporation, filed a complaint in the U.S. District Court for Southern District of New York against the Company and certain of its directors and officers, captioned David Katz and Thomas Wightman, on behalf of iRobot Corporation v. iRobot Corporation, et al., No. 1:19-cv-11692. The complaint alleges breaches of fiduciary duties, unjust enrichment, violations of Sections 10(b) and 20(a) of the Exchange Act and Rule 10b-5 thereunder based on allegedly false and misleading statements and omissions concerning the Company's acquisitions of Sales on Demand Corporation and Robopolis SAS and the Company's subsequent financial performance. The complaint seeks, among other things, unspecified compensatory damages, including
15

iROBOT CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - (continued)
interest, in connection with the Company's allegedly inflated stock price, attorneys' fees and costs, and unspecified equitable/injunctive relief. This case has been transferred to the U.S. District Court for the District of Massachusetts. Similarly, additional derivative litigations -- namely: Robert Truman, on behalf of iRobot Corporation v. iRobot Corporation, et al., No. 1:20-cv-10034; Alexa Ruhfass, on behalf of iRobot Corporation v. iRobot Corporation, et al., No. 1:20-cv-10133; and William Tasco, derivatively on behalf of iRobot Corporation v. iRobot Corporation, et al., No. 1:20-cv-10253 - were filed in the U.S. District Court for the District of Massachusetts. All of these cases have been consolidated in a case captioned as In re iRobot Corporation Derivative litigation, No. 1:20-cv-10034. On May 4, 2021, the parties filed a joint stipulation with the U.S. District Court for the District of Massachusetts seeking dismissal of this case.
Guarantees and Indemnification Obligations
The Company enters into standard indemnification agreements in the ordinary course of business. Pursuant to these agreements, the Company indemnifies and agrees to reimburse the indemnified party for losses incurred by the indemnified party, generally the Company’s customers, in connection with any patent, copyright, trade secret or other proprietary right infringement claim by any third party. The term of these indemnification agreements is generally perpetual any time after execution of the agreement. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is unlimited. The Company has never incurred costs to defend lawsuits or settle claims related to these indemnification agreements. As a result, the Company believes the estimated fair value of these agreements is minimal. Accordingly, the Company has no liabilities recorded for these agreements as of April 3, 2021 and January 2, 2021, respectively.
Warranty
The Company provides warranties on most products and has established a reserve for warranty obligations based on estimated warranty costs. The reserve is included as part of accrued expenses (Note 6) in the accompanying consolidated balance sheets.    
Activity related to the warranty accrual was as follows (in thousands):
 Three Months Ended
 April 3, 2021March 28, 2020
Balance at beginning of period$24,392 $13,856 
Provision10,185 4,475 
Warranty usage(10,673)(4,333)
Balance at end of period$23,904 $13,998 

11. Income Taxes
The Company’s effective income tax rate for the three months ended April 3, 2021 and March 28, 2020, was (19.5)% and 10.4%, respectively. The change in the effective income tax rate was primarily due to the recognition of a discrete tax benefit related to stock-based compensation during the period compared to a discrete tax expense during prior year.
The Company's effective income tax rate of (19.5)% for the three months ended April 3, 2021 differed from the federal statutory tax rate of 21% primarily due to the recognition of a discrete tax benefit related to stock-based compensation.
    
12. Industry Segment, Geographic Information and Significant Customers
The Company operates as one operating segment. The Company's consumer robots products are offered to consumers through a variety of distribution channels, including chain stores and other national retailers, through the Company's own website and app, dedicated e-commerce websites, the online arms of traditional retailers, and through value-added distributors and resellers worldwide.
Significant Customers
For the three months ended April 3, 2021 and March 28, 2020, the Company generated 17.0% and 13.4% of total revenue, respectively, from one of its retailers.


16



Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The information contained in this section has been derived from our consolidated financial statements and should be read together with our consolidated financial statements and related notes included elsewhere in this Quarterly Report on Form 10-Q. This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended, (the "Exchange Act"), and are subject to the "safe harbor" created by those sections. In particular, statements contained in this Quarterly Report on Form 10-Q that are not historical facts, including, but not limited to statements concerning the impact of COVID-19 on our business, new product sales, product development and offerings, our consumer robots, our competition, our strategy, our market position, market acceptance of our products, seasonal factors, revenue recognition, our profits, growth of our revenues, composition of our revenues, our cost of revenues, units shipped, average selling prices, the impact of promotional activity and tariffs, operating expenses, diversification of our manufacturing supply chain, selling and marketing expenses, general and administrative expenses, research and development expenses, and compensation costs, our projected income tax rate, our credit and letter of credit facilities, our valuations of investments, valuation and composition of our stock-based awards, and liquidity, constitute forward-looking statements and are made under these safe harbor provisions. Some of the forward-looking statements can be identified by the use of forward-looking terms such as "believes," "expects," "may," "will," "should," "could," "seek," "intends," "plans," "estimates," "anticipates," or other comparable terms. Forward-looking statements involve inherent risks and uncertainties, which could cause actual results to differ materially from those in the forward-looking statements. We urge you to consider the risks and uncertainties discussed in greater detail under the heading "Risk Factors" in this Quarterly Report on Form 10-Q and in Part I, "Item 1A. Risk Factors" in our Annual Report on Form 10-K for the year ended January 2, 2021 in evaluating our forward-looking statements. We have no plans to update our forward-looking statements to reflect events or circumstances after the date of this report. We caution readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made.

Overview
iRobot is a leading global consumer robot company that designs and builds robots that empower people to do more. Our consumer robots help people find smarter ways to clean and accomplish more in their daily lives. iRobot's portfolio of floor cleaning robots features proprietary technologies for the connected home and advanced concepts in cleaning, mapping and navigation, human-robot interaction and physical solutions. Leveraging this portfolio, our engineers are building an ecosystem of robots to help realize the smart home’s potential. For more than 30 years, we have been a pioneer and leader in consumer robotics, robotic floor care and robotic artificial intelligence.
As of April 3, 2021, we had 1,267 full-time employees. Since our founding in 1990, we have developed expertise in the disciplines necessary to design, build, sell and support durable, high-performance and cost-effective robots through the close integration of software, electronics and hardware. Our core technologies serve as reusable building blocks that we adapt and expand to create next-generation robotic platforms. We believe that this approach accelerates the time to market, while also reducing the costs and risks associated with product development. These capabilities are amplified by the integration of artificial intelligence, home understanding and machine vision technologies that further improve cleaning performance and help personalize the cleaning experience, enabling customers to have greater control over where, when and how our robots clean. We believe that our significant expertise in robot design, engineering, and smart home technologies and targeted focus on understanding and addressing consumer needs, positions us well to capitalize on the anticipated growth in the market for robot-based consumer products.
From September 2018 until April 2020, our Roomba products were subject to Section 301 tariffs. In April 2020, we were granted a temporary exclusion from Section 301 List 3 tariffs by the United States Trade Representative ("USTR"). This exclusion, as extended in August 2020, eliminated the 25% tariff on Roomba products imported from China until December 31, 2020 and entitled us to a refund of approximately $57.0 million in tariffs paid since the date the Section 301 List 3 tariffs were imposed. Effective January 1, 2021, the 25% Section 301 tariff again applies to our Roomba products imported from China. We expect this incremental cost will reduce our gross profit in 2021. To diversify our manufacturing and help offset the adverse financial impact on our business of the 25% Section 301 tariff, we are focused on scaling the manufacture of our products in Malaysia. We commenced production of our products in Malaysia in late 2019 with the current goal of being capable of manufacturing broadly and at scale in Malaysia by the end of 2021.
To continue expanding our business globally and increase our profitability in a highly competitive marketplace, we have continued to make progress on each key element of our strategy: 1) differentiating the iRobot experience; 2) building strong relationships with the consumer; and 3) nurturing the lifetime value of our customer relationships.
We strive to differentiate the iRobot experience through the ongoing innovation of our existing product offerings and by bringing new products to market. During the first quarter of 2021, we enhanced the iRobot Genius Home Intelligence Platform, a powerful AI-based robot platform that gives users greater personalization and control over their cleaning robots. In January 2021, we launched Roomba i3 Series in EMEA and Japan following a successful introduction of this product in North America
17



in September 2020. We believe that the Roomba i3 Series will play an important role in strengthening the mid-tier of our product portfolio.
To continue building strong relationships with our consumers worldwide, we are focused on enhancing all aspects of the consumer experience, including investing in our digital marketing and e-commerce capabilities. At the end of the first quarter of 2021, we increased our connected customer base to 10.7 million customers who have opted in to our digital communications, up 74% from the same period one year ago.
We also continued to make important progress in nurturing the lifetime value of our customer relationships. In early April 2021, we introduced our new iRobot H1 handheld vacuum, enabling customers to purchase a complementary vacuum to clean in areas that our Roomba or Braava robots are typically unable to reach. In addition, we are now offering extended warranty plans to customers who purchase our products directly from us, and we advanced pilot programs for high-value services that offer customers greater flexibility with how they can purchase our products and accessories. High-value services currently being tested by consumers include iRobot Select, a membership program in which owners pay an initiation fee along with a recurring monthly fee to use their robot along with dedicated customer support and accessories on demand, and a maintenance program in which owners pay a monthly fee for personalized support and accessories. Since the start of the pandemic over a year ago, more consumers are buying our products online. Overall, our direct-to-consumer sales grew 146% in the first quarter and generated 12% of our revenue for the quarter ended April 3, 2021.
Key Metrics
In addition to the measures presented in our consolidated financial statements in accordance with accounting principles generally accepted in the United States of America ("GAAP"), we use the following key metrics, including non-GAAP financial measures, to evaluate and analyze our core operating performance and trends, and to develop short-term and long-term operational plans. A summary of key metrics for the three months ended April 3, 2021, as compared to the three months ended March 28, 2020, is as follows:
 Three Months Ended
 April 3, 2021March 28, 2020
(dollars in thousands, except average gross selling prices)
(unaudited)
Total Revenue$303,261 $192,535 
Non-GAAP Gross Profit$123,531 $78,767 
Non-GAAP Gross Margin40.7 %40.9 %
Non-GAAP Operating Income (Loss)$14,954 $(14,380)
Non-GAAP Operating Margin4.9 %(7.5)%
Total robot units shipped (in thousands)1,088 721 
Average gross selling prices for robot units$319 $315 

Use of Non-GAAP Financial Measures
Our non-GAAP financial measures reflect adjustments based on the following items. We exclude these items from our non-GAAP measures to facilitate an evaluation of our current operating performance and comparisons to our past operating performance. These items may vary significantly in magnitude or timing and do not necessarily reflect anticipated future operating activities. In addition, we believe that providing these non-GAAP measures affords investors a view of our operating results that may be more easily compared with our peer companies. These non-GAAP financial measures should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and the financial results calculated in accordance with GAAP and reconciliations from these results, provided below, should be carefully evaluated.
Amortization of acquired intangible assets: Amortization of acquired intangible assets consists of amortization of intangible assets including completed technology, customer relationships, and reacquired distribution rights acquired in connection with business combinations. Amortization charges for our acquisition-related intangible assets are inconsistent in size and are significantly impacted by the timing and valuation of our acquisitions.
18



Tariff Refunds: iRobot was granted a Section 301 List 3 Tariff Exclusion in April 2020, which temporarily eliminates tariffs on the Company’s products imported from China until December 31, 2020 and entitles the Company to a refund of all related tariffs previously paid since September 2018. We exclude the refunds for tariff costs expensed during fiscals 2018 and 2019 from our fiscal 2020 non-GAAP measures because those tariff refunds associated with tariff costs incurred in the past have no impact to our current period earnings.
Net Merger, Acquisition and Divestiture (Income) Expense: Net merger, acquisition and divestiture (income) expense primarily consists of transaction fees, professional fees, and transition and integration costs directly associated with mergers, acquisitions and divestitures. It also includes business combination adjustments after the measurement period has ended.
Stock-Based Compensation: Stock-based compensation is a non-cash charge relating to stock-based awards.
IP Litigation Expense, Net: IP litigation expense, net relates to legal costs incurred to litigate patent, trademark, copyright and false advertising infringements, or to oppose or defend against interparty actions related to intellectual property. Any settlement payment or proceeds resulting from these infringements are included or netted against the costs.
Gain/Loss on Strategic Investments: Gain/loss on strategic investments includes fair value adjustments, realized gains and losses on the sales of these investments and losses on the impairment of these investments.
Restructuring and Other: Restructuring charges are related to one-time actions associated with workforce reductions, including severance costs, certain professional fees and other costs directly associated with resource realignments tied to strategic initiatives or changes in business conditions.
Income tax adjustments: Income tax adjustments include the tax effect of the non-GAAP adjustments, calculated using the appropriate statutory tax rate for each adjustment. We reassess the need for any valuation allowance recorded based on the non-GAAP profitability and have eliminated the effect of the valuation allowance recorded in the U.S. jurisdiction. We also exclude certain tax items that are not reflective of income tax expense incurred as a result of current period earnings. These certain tax items include, among other non-recurring tax items, impacts from the Tax Cuts and Jobs Act of 2017 and stock-based compensation windfalls/shortfalls.

19



The following table reconciles gross profit, operating income (loss), net income (loss) and net income (loss) per share on a GAAP and non-GAAP basis for the three months ended April 3, 2021 and March 28, 2020 (dollars in thousands, other than per share data):
Three Months Ended
April 3, 2021March 28, 2020
 GAAP Gross Profit$122,944 $77,955 
   Amortization of acquired intangible assets225 285 
   Stock-based compensation362 527 
 Non-GAAP Gross Profit$123,531 $78,767 
 Non-GAAP Gross Margin40.7 %40.9 %
 GAAP Operating Income (Loss)$6,389 $(20,225)
   Amortization of acquired intangible assets430 539 
   Stock-based compensation6,782 5,191 
   Net merger, acquisition and divestiture income— (500)
   IP litigation expense, net1,140 615 
   Restructuring and other213 — 
 Non-GAAP Operating Income (Loss)$14,954 $(14,380)
 Non-GAAP Operating Margin4.9 %(7.5)%
 GAAP Net Income (Loss)$7,443 $(18,135)
   Amortization of acquired intangible assets430 539 
   Stock-based compensation6,782 5,191 
   Net merger, acquisition and divestiture income— (500)
   IP litigation expense, net1,140 615 
   Restructuring and other213 — 
   Gain on strategic investments(38)(87)
   Income tax effect(4,051)3,215 
 Non-GAAP Net Income (Loss)$11,919 $(9,162)
 GAAP Net Income (Loss) Per Diluted Share$0.26 $(0.64)
   Dilutive effect of non-GAAP adjustments0.15 0.32 
 Non-GAAP Net Income (Loss) Per Diluted Share$0.41 $(0.32)

Critical Accounting Policies and Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, revenue and expenses. These estimates and judgments, include but are not limited to, revenue recognition including performance obligations, variable consideration and other obligations such as product returns and incentives; allowance for credit losses; product warranties; valuation of goodwill and acquired intangible assets; valuation of non-marketable equity investments; evaluating loss contingencies; accounting for stock-based compensation including performance-based assessments; and accounting for income taxes and related valuation allowances. We base these estimates and judgments on historical experience, market participant fair value considerations, projected future cash flows and various other factors that we believe are reasonable under the circumstances. Actual results may differ from our estimates. Additional information about these critical accounting policies may be found in the "Management’s Discussion and Analysis of Financial Condition and Results of Operations" section included in our Annual Report on Form 10-K for the fiscal year ended January 2, 2021.

20



Overview of Results of Operations
The following table sets forth our results of operations as a percentage of revenue:
 Three Months Ended
 April 3, 2021March 28, 2020
Revenue100.0 %100.0 %
Cost of revenue:
Cost of product revenue59.4 59.4 
Amortization of acquired intangible assets0.1 0.1 
Total cost of revenue59.5 59.5 
Gross profit40.5 40.5 
Operating expenses:
Research and development13.8 19.1 
Selling and marketing16.8 19.0 
General and administrative7.7 12.8 
Amortization of acquired intangible assets0.1 0.1 
Total operating expenses38.4 51.0 
Operating income (loss)2.1 (10.5)
Other expense, net— — 
Income (loss) before income taxes2.1 (10.5)
Income tax benefit(0.4)(1.1)
Net income (loss)2.5 %(9.4)%
Comparison of Three Months Ended April 3, 2021 and March 28, 2020
Revenue
 Three Months Ended
 April 3, 2021March 28, 2020Dollar
Change
Percent
Change
  (Dollars in thousands) 
Revenue$303,261 $192,535 $110,726 57.5 %
Revenue for the three months ended April 3, 2021 increased $110.7 million to $303.3 million, or 57.5%, compared to $192.5 million for the three months ended March 28, 2020. The $110.7 million increase in revenue was primarily attributable to a 50.9% increase in units shipped for the three months ended April 3, 2021 compared to the three months ended March 28, 2020. During the first quarter of 2020, our ability to fulfill demand for certain products was negatively impacted by supply chain challenges, which was compounded by the impact of the start of the COVID-19 pandemic on our organization, our contractors and our suppliers. In the three months ended April 3, 2021, domestic revenue increased $32.8 million, or 40.0%, while international revenue increased $77.9 million, or 70.5% due primarily to 74.4% growth in EMEA and a 53.3% increase in Japan.
Cost of Product Revenue
 Three Months Ended
 April 3, 2021March 28, 2020Dollar
Change
Percent
Change
 (Dollars in thousands)
Cost of product revenue$180,092 $114,295 $65,797 57.6 %
As a percentage of revenue59.4 %59.4 %
Cost of product revenue increased to $180.1 million in the three months ended April 3, 2021, compared to $114.3 million in the three months ended March 28, 2020. The $65.8 million increase in cost of product revenue is primarily due to the 57.5% increase in revenue.
21



Gross Profit
 Three Months Ended
 April 3, 2021March 28, 2020Dollar
Change
Percent
Change
 (Dollars in thousands)
Gross profit$122,944 $77,955 $44,989 57.7 %
Gross margin40.5 %40.5 %
Gross margin remained consistent at 40.5% in the three months ended April 3, 2021, compared to the three months ended March 28, 2020. Changes in pricing and promotion, higher air freight fees and higher costs to procure certain components were offset by leverage from higher sales, lower tariff costs and favorable channel mix. We expect to see gross margin pressure over the next few quarters as we anticipate increases in raw materials, freight and transportation costs as well as higher component costs associated with limited semiconductor chip availability.
Research and Development
 Three Months Ended
 April 3, 2021March 28, 2020Dollar
Change
Percent
Change
 (Dollars in thousands)
Research and development$41,920 $36,759 $5,161 14.0 %
As a percentage of revenue13.8 %19.1 %
Research and development expenses increased $5.2 million, or 14.0%, to $41.9 million (13.8% of revenue) in the three months ended April 3, 2021 from $36.8 million (19.1% of revenue) in the three months ended March 28, 2020. This increase is primarily due to a $3.3 million increase in people-related costs and a $1.8 million increase in program-related costs.
Selling and Marketing
 Three Months Ended
 April 3, 2021March 28, 2020Dollar
Change
Percent
Change
 (Dollars in thousands)
Selling and marketing$50,990 $36,594 $14,396 39.3 %
As a percentage of revenue16.8 %19.0 %
Selling and marketing expenses increased $14.4 million, or 39.3%, to $51.0 million (16.8% of revenue) in the three months ended April 3, 2021 from $36.6 million (19.0% of revenue) in the three months ended March 28, 2020. This increase was primarily attributable to an $11.1 million increase in marketing spend associated with working media to drive sales growth and to build and support our direct-to consumer sales channel, as well as a $3.2 million increase in people-related costs.
General and Administrative
 Three Months Ended
 April 3, 2021March 28, 2020Dollar
Change
Percent
Change
 (Dollars in thousands)
General and administrative$23,440 $24,573 $(1,133)(4.6)%
As a percentage of revenue7.7 %12.8 %
General and administrative expenses decreased $1.1 million, or 4.6%, to $23.4 million (7.7% of revenue) in the three months ended April 3, 2021 from $24.6 million (12.8% of revenue) in the three months ended March 28, 2020. This decrease is primarily due to the change in the allowance for credit loss. During the three months ended April 3, 2021, the allowance for credit loss decreased $2.1 million as a result of improved financial conditions and credit rating for certain customer accounts. During the three months ended March 28, 2020, the allowance for credit loss increased by $4.5 million due to concerns about certain customers' ability to successfully navigate the pandemic. This decrease is offset by higher people-related costs of $4.3
22



million attributable to higher performance-based stock-based compensation and short-term incentive compensation as well as an increase in legal fees of $1.2 million driven by higher intellectual property litigation costs.
Amortization of Acquired Intangible Assets
 Three Months Ended
 April 3, 2021March 28, 2020Dollar
Change
Percent
Change
 (Dollars in thousands)
Cost of revenue$225 $285 $(60)(21.1)%
Operating expense205 254 (49)(19.3)%
Total amortization expense$430 $539 $(109)(20.2)%
As a percentage of revenue0.1 %0.3 %
The amortization of acquired intangible assets was immaterial in the three months ended April 3, 2021 and March 28, 2020.
Other Expense, Net
 Three Months Ended
 April 3, 2021March 28, 2020Dollar
Change
Percent
Change
 (Dollars in thousands)
Other expense, net$(160)$(19)$(141)742.1 %
As a percentage of revenue— %— %
Other expense, net, amounted to $0.2 million and $0.0 million for the three months ended April 3, 2021 and March 28, 2020, respectively. Other expense, net includes interest income, interest expense, foreign currency gains (losses) as well as gains (losses) from strategic investments.

Income Tax Benefit
 Three Months Ended
 April 3, 2021March 28, 2020Dollar
Change
Percent
Change
 (Dollars in thousands)
Income tax benefit$(1,214)$(2,109)$895 (42.4)%
Effective income tax rate(19.5)%10.4 %
We recorded an income tax benefit of $1.2 million and $2.1 million for the three months ended April 3, 2021 and March 28, 2020, respectively. The $1.2 million income tax benefit for the three months ended April 3, 2021 resulted in an effective income tax rate of (19.5)%. The $2.1 million income tax benefit for the three months ended March 28, 2020 resulted in an effective income tax rate of 10.4%. The change in the effective income tax rate was primarily due to the recognition of a discrete tax benefits related to stock-based compensation during the period compared to a discrete tax expense during prior year.
Our effective income tax rate of (19.5)% for the three months ended April 3, 2021 differed from the federal statutory tax rate of 21% primarily due to the recognition of a discrete tax benefits related to stock-based compensation.
The effective tax rate for interim periods is determined based upon our estimated annual effective tax rate, adjusted for the effect of discrete items arising in that quarter. The impact of such inclusions could result in a higher or lower effective tax rate during a quarter, based upon the geographic mix and timing of our actual earnings or losses versus annual projections.

23



Liquidity and Capital Resources
At April 3, 2021, our principal sources of liquidity were cash and cash equivalents totaling $500.8 million. Our working capital was $579.3 million as of April 3, 2021, compared to $573.7 million as of January 2, 2021.
We manufacture and distribute our products through contract manufacturers and third-party logistics providers. We believe this approach gives us the advantages of relatively low capital investment and significant flexibility in scheduling production and managing inventory levels. By leasing our office facilities, we also minimize the cash needed for expansion, although we invest periodically in upgrading these facilities, a portion of which investment will be reimbursed by the landlords of these facilities. Accordingly, our capital spending is generally limited to machinery and tooling, leasehold improvements, business applications software and computer and equipment. In the three months ended April 3, 2021 and March 28, 2020, we spent $11.3 million and $7.3 million, respectively, on capital expenditures.
Our strategy for delivering consumer products to our distributors and retail customers gives us the flexibility to provide container shipments directly from our contract manufacturers in Southern China and Malaysia to our customers and, alternatively, allows our distributors and certain retail customers to take possession of product on a domestic basis. Accordingly, our inventory consists of goods shipped to our third-party logistics providers for the fulfillment of distributor, retail and direct-to-consumer sales. Our contract manufacturers are also responsible for purchasing and stocking components required for the production of our products, and they typically invoice us when the finished goods are shipped.
Cash provided by operating activities
Net cash provided by operating activities for the three months ended April 3, 2021 was $28.7 million, of which the principal components were our net income of $7.4 million, non-cash charges of $15.8 million and cash inflow of $5.5 million from change in working capital. The change in working capital was driven by decreases in accounts receivable of $101.5 million and accounts payable and accrued liabilities of $48.0 million. This was partially offset by an increase in inventory of $51.4 million.
Cash provided by (used in) investing activities
Net cash provided by investing activities for the three months ended April 3, 2021 was $43.7 million. During the three months ended April 3, 2021, we received $63.6 million from the sales and maturities of our investments while we paid $8.7 million for the purchases of investments. We invested $11.3 million in the purchase of property and equipment, including machinery and tooling for new products and manufacturing expansion in Malaysia.
Cash used in financing activities
Net cash used in financing activities for the three months ended April 3, 2021 was $2.2 million. During the three months ended April 3, 2021, we received $2.6 million from employee stock plans and paid $4.8 million upon vesting of restricted stock where approximately 41,033 shares were retained by us to cover employee tax withholdings.
Working Capital Facilities
Credit Facility
In June 2018, we entered into a new agreement with Bank of America, N.A., increasing the amount of our unsecured revolving line of credit from $75.0 million to $150.0 million and extending the term of the credit facility to June 2023. As of April 3, 2021, we had no outstanding borrowings under our revolving credit facility. The revolving line of credit is available to fund working capital and other corporate purposes. The interest on loans under our credit facility accrues, at our election, at either (1) LIBOR plus a margin, currently equal to 1.0%, based on our ratio of indebtedness to Adjusted EBITDA (the "Eurodollar Rate"), or (2) the lender’s base rate. The lender’s base rate is equal to the highest of (1) the federal funds rate plus 0.5%, (2) the lender’s prime rate and (3) the Eurodollar Rate plus 1.0%. In the event that LIBOR is discontinued as expected in 2023, we expect the interest rates for our debt following such event will be based on either alternate base rates or agreed upon replacement rates. While we do not expect a LIBOR discontinuation would affect our ability to borrow or maintain already outstanding borrowings, it could result in higher interest rates.
The credit facility contains customary terms and conditions for credit facilities of this type, including restrictions on our ability to incur or guarantee additional indebtedness, create liens, enter into transactions with affiliates, make loans or investments, sell assets, pay dividends or make distributions on, or repurchase, our stock, and consolidate or merge with other entities. In addition, we are required to meet certain financial covenants customary with this type of agreement, including maintaining a maximum ratio of indebtedness to Adjusted EBITDA and a minimum specified interest coverage ratio.
The credit facility contains customary events of default, including for payment defaults, breaches of representations, breaches of affirmative or negative covenants, cross defaults to other material indebtedness, bankruptcy and failure to discharge certain judgments. If a default occurs and is not cured within any applicable cure period or is not waived, our obligations under the credit facility may be accelerated.
24



As of April 3, 2021, we were in compliance with all covenants under the revolving credit facility.
Lines of Credit
We have an unsecured letter of credit facility with Bank of America, N.A., available to fund letters of credit up to an aggregate outstanding amount of $5.0 million. As of April 3, 2021, we had letters of credit outstanding of $0.7 million under our letter of credit facility and other lines of credit with Bank of America, N.A.
We have an unsecured guarantee line of credit with Mizuho, Bank Ltd., available to fund import tax payments up to an aggregate outstanding amount of 250.0 million Japanese Yen. As of April 3, 2021, we had no outstanding balance under the guarantee line of credit. 
Working Capital and Capital Expenditure Needs
We currently have no material cash commitments, except for normal recurring trade payables, expense accruals, capital expenditures and operating leases, all of which we anticipate funding through working capital and funds provided by operating activities. We believe our outsourced approach to manufacturing provides us with flexibility in both managing inventory levels and financing our inventory. We believe our existing cash and cash equivalents, short-term investments, and funds available through our credit facility will be sufficient to meet our working capital and capital expenditure needs over at least the next twelve months. In the event our revenue plan does not meet our expectations, we may eliminate or curtail expenditures to mitigate the impact on our working capital. Our future capital requirements will depend on many factors, including our rate of revenue growth or decline, the expansion or contraction of our marketing and sales activities, the timing and extent of spending to support product development efforts, the timing of introductions of new products and enhancements to existing products, the acquisition of new capabilities or technologies, the continuing market acceptance of our products and services, and the impact of COVID-19 on our business. Moreover, to the extent existing cash and cash equivalents, short-term investments, cash from operations, and cash from short-term borrowing are insufficient to fund our future activities, we may need to raise additional funds through public or private equity or debt financing. As part of our business strategy, we may consider additional acquisitions of companies, technologies and products, which could also require us to seek additional equity or debt financing. Additional funds may not be available on terms favorable to us or at all.
Share Repurchases
As of April 3, 2021, we were authorized to purchase up to $200.0 million of our common stock under a share repurchase program, of which $25.0 million was utilized in the first quarter of 2020. On March 11, 2021, we entered into a Rule 10b5-1 plan to repurchase $50.0 million of common stock in the aggregate beginning April 12, 2021 and ending September 5, 2021. We purchased 446,954 shares of our common stock at an average price of $111.85, totaling $50.0 million during the second quarter of 2021. As of May 6, 2021, $125.0 million remained available for future repurchases under the program. Our share repurchase program does not obligate us to acquire any specific number of shares.
Contractual Obligations
The disclosure of our contractual obligations and commitments is set forth under the heading "Management's Discussion and Analysis of Financial Condition and Results of Operations - Contractual Obligations" in our Annual Report on Form 10-K for the year ended January 2, 2021. Our principal commitments generally consist of obligations under our credit facility, leases for office space and minimum contractual obligations. Other obligations primarily consist of subscription services. There have been no material changes in our contractual obligations and commitments since January 2, 2021.
At April 3, 2021, we had outstanding purchase orders aggregating approximately $545.1 million. The purchase orders, the majority of which are with our contract manufacturers for the purchase of inventory in the normal course of business, are for manufacturing and non-manufacturing related goods and services, and are generally cancellable without penalty. In circumstances where we have determined that we have financial exposure associated with any of these commitments, we record a liability in the period in which that exposure is identified.
Off-Balance Sheet Arrangements
As of April 3, 2021, we had no off-balance sheet arrangements as defined in Item 303(a)(4) of Regulation S-K.
Recently Adopted Accounting Pronouncements
See Note 2 to the Consolidated Financial Statements for a discussion of recently adopted accounting pronouncements.
Recently Issued Accounting Pronouncements
See Note 2 to the Consolidated Financial Statements for a discussion of recently issued accounting pronouncements.
25



Item 3. Quantitative and Qualitative Disclosure About Market Risk
Exchange Rate Sensitivity
Our international revenue and expenses are denominated in multiple currencies, including British Pounds, Canadian Dollars, Chinese Renminbi, Euros and Japanese Yen. As such, we have exposure to adverse changes in exchange rates associated with the revenue and operating expenses of our foreign operations. Any fluctuations in other currencies will have minimal direct impact on our international revenue.
In addition to international business conducted in foreign currencies, we have international revenue denominated in U.S. dollars. As the U.S. dollar strengthens or weakens against other currencies, our international distributors may be impacted, which could affect their profitability and our ability to maintain current pricing levels on our international consumer products.
We regularly monitor the forecast of non-U.S. dollar revenue and expenses and the level of non-U.S. dollar monetary asset and liability balances to determine if any actions, including possibly entering into foreign currency contracts should be taken to minimize the impact of fluctuating exchange rates on our results of operations. Periodically, we enter into forward exchange contracts to hedge against foreign currency fluctuations. These contracts may or may not be designated as cash flow hedges for accounting purposes. We use cash flow hedges primarily to reduce the effects of foreign exchange rate changes on sales in Euros and Japanese Yen. At April 3, 2021 and January 2, 2021, we had outstanding cash flow hedges with a total notional value of $397.8 million and $431.9 million, respectively.
We also enter into economic hedges that are not designated as hedges from an accounting standpoint to reduce or eliminate the effects of foreign exchange rate changes typically related to short term trade receivables and payables. These contracts have maturities of twelve months or less. At April 3, 2021 and January 2, 2021, we had outstanding economic hedges with a total notional value of $140.5 million and $192.2 million, respectively.
At April 3, 2021, assuming all other variables are constant, if the U.S. Dollar weakened or strengthened by 10%, the fair market value of our foreign currency contracts would increase or decrease by approximately $39.1 million.
Item 4. Controls and Procedures
Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) of the Exchange Act as of the end of the period covered by this report. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures as of the end of the period covered by this report were effective at a reasonable assurance level in ensuring that information required to be disclosed by us in reports that we file or submit under the Exchange Act (i) is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms; and (ii) accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely discussions regarding required disclosure. We believe that a control system, no matter how well designed and operated, cannot provide absolute assurance that the objectives of the control system are met, and no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected.
There was no change in our internal control over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act) that occurred during the period covered by this report that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
Part II. Other Information
Item 1. Legal Proceedings
This information is included in Note 10, Commitments and Contingencies, in the accompanying notes to the unaudited consolidated financial statements and is incorporated herein by reference from Item 1 of Part I.

Item 1A. Risk Factors
We operate in a rapidly changing environment that involves a number of risks that could materially affect our business, financial condition or future results, some of which are beyond our control. In addition to the other information set forth in this report, the risks and uncertainties that we believe are most important for you to consider are discussed in Part I, "Item 1A. Risk Factors" in our Annual Report on Form 10-K for the year ended January 2, 2021, which could materially affect our business, financial condition or future results. Additional risks and uncertainties not presently known to us, which we currently deem immaterial or which are similar to those faced by other companies in our industry or business in general, may also impair our business operations. There are no material changes to the Risk Factors described in our Annual Report on Form 10-K for the year ended January 2, 2021, other than as set forth below:
26



We depend on a limited number of manufacturers and on a wide range of materials and components, and our reputation and results of operations would be harmed if these manufacturers fail to meet our requirements, or if we are delayed in obtaining or are unable to obtain certain materials and components.
We depend on a limited number of manufacturers, employing a dual-source strategy to mitigate potential manufacturing disruptions, and we have safety stock strategies for low-volume products that are not dual sourced. The majority of our contract manufacturing locations for our robots are currently located in China and we began adding additional manufacturing capacity in Malaysia in late 2019, where we have ramped up, and expect to continue to ramp up production in 2021. These manufacturers manage the supply chain for all of the raw materials and provide all facilities and labor required to manufacture our products. If these companies were to terminate their arrangements with us or fail to provide the required capacity and quality on a timely basis, there would be a disruption in manufacturing our products until replacement contract manufacturing services could be obtained or volume transferred to an alternative manufacturing partner, each of which is a costly and time-consuming process. We cannot assure you that we would be able to establish alternative manufacturing arrangements on acceptable terms or in a timely manner.
We are dependent on a limited number of suppliers for various components used in our products, and we may from time to time have sole source suppliers. The cost, quality and availability of these components are essential to the successful production and sale of our products. Global component shortages are likely to result in price fluctuations, long lead times in the supply of these components and the inability to fulfill orders from customers in a timely manner or at all, or on a cost basis that allows us to maintain our level of profitability. More recently, we have seen, and anticipate that we will continue to see global supply chain challenges including limits on various semiconductor devices as demand has steadily increased for a wide range of goods that rely on these components. These impacts on our supply chain have adversely impacted, and may continue to adversely impact, our ability to meet our product demand, result in additional costs, result in customer dissatisfaction in the event of continued inventory shortages or may otherwise adversely impact our business and results of operations.
If the supply of any component used in manufacturing our products were to be delayed or constrained, or if one or more of our main suppliers were to go out of business, alternative sources or suppliers may not be available on acceptable terms or at all. In the event that any of our suppliers were to discontinue production of our key product components, developing alternate sources of supply for these components would be time consuming, difficult and costly. In the event we are unable to obtain components in sufficient quantities on a timely basis and on commercially reasonable terms, our ability to sell our products in order to meet market demand would be affected and could materially and adversely affect our brand, image, business prospects, financial condition and operating results.
Our reliance on these contract manufacturers involves certain risks, including the following:
lack of direct control over production capacity and delivery schedules;
lack of direct control over quality assurance, manufacturing yields and production costs;
lack of enforceable contractual provisions over the production and costs of consumer products;
risk of loss of inventory while in transit;
risks associated with international commerce, including unexpected changes in legal and regulatory requirements, changes in tariffs and trade policies, risks associated with the protection of intellectual property and political and economic instability; and
risks that our attempts to add additional manufacturing resources may be significantly delayed and thereby create disruptions in production of our products.
Any interruption in the manufacture of our products would be likely to result in delays in shipment, lost sales and revenue and damage to our reputation in the market, all of which would harm our business and results of operations. In addition, because our purchase contracts with suppliers are typically denominated in U.S. dollars, changes in currency exchange rates may impact our suppliers who operate in local currency, which may cause our suppliers to seek price concessions on future orders.
27



Item 5. Other Information
10b5-1 Trading Plans
Our policy governing transactions in our securities by our directors, officers, and employees permits our officers, directors, funds affiliated with our directors, and certain other persons to enter into trading plans complying with Rule 10b5-l under the Exchange Act. We have been advised that certain of our officers and directors (including Colin Angle, Chief Executive Officer, and Glen Weinstein, EVP and Chief Legal Officer, as well as Mohamad Ali, Deborah Ellinger, Elisha Finney, and Rueybin Kao, each a director of the Company) have entered into trading plans (each a "Plan" and collectively, the "Plans") covering periods after the date of this Quarterly Report on Form 10-Q in accordance with Rule 10b5-l and our policy governing transactions in our securities. Generally, under these trading plans, the individual relinquishes control over the transactions once the trading plan is put into place. Accordingly, sales under these plans may occur at any time, including possibly before, simultaneously with, or immediately after significant events involving the Company.
We anticipate that, as permitted by Rule 10b5-1 and our policy governing transactions in our securities, some or all of our officers, directors and employees may establish trading plans in the future. We intend to disclose the names of our executive officers and directors who establish a trading plan in compliance with Rule 10b5-1 and the requirements of our policy governing transactions in our securities in our future quarterly and annual reports on Form 10-Q and 10-K filed with the Securities and Exchange Commission. We undertake no obligation to update or revise the information provided herein.


28



Item 6. Exhibits
 
EXHIBIT INDEX
Exhibit
Number
 Description
 Certification Pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934
 Certification Pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934
 Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.SCH*Inline XBRL Taxonomy Extension Schema Document
101.CAL*Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.LAB*Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE*Inline XBRL Taxonomy Extension Presentation Linkbase Document
101.DEF*Inline XBRL Taxonomy Extension Definition Linkbase Document
104*Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extension information contained in Exhibits 101.*)
 __________________________
*Filed herewith
**Furnished herewith


29



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
iROBOT CORPORATION
Date: May 6, 2021
By:/s/ Julie Zeiler
Julie Zeiler
Executive Vice President and Chief Financial Officer (Principal Financial Officer)
30